Over half a decade, Abbott Laboratories managed to grow its earnings per share at 12% a year. The EPS growth is more ...

As Abbott Laboratories prepares to build a plant and bring 450 jobs to Bowling Green, company officials asked for permission to have more fencing and less greenery than required by city zoning. On ...

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

CNBC’s Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that’s been weighed down by ...

周一，巴克莱维持对Abbott Labs (NYSE:ABT)股票的增持评级，并将目标价从143美元上调至149美元。此次调整是在Abbott最近在圣路易斯的NEC诉讼中获得有利裁决后做出的。巴克莱分析师表示，尽管该股近期已有所上涨，包括从7月低点上涨18%，但距离他们对公司股票的新目标价仍有超过25%的上涨空间。

2024 Abbott Laboratories shares rose nearly 5% before the bell on Friday, after a jury cleared the company and a Reckitt unit of liability in a lawsuit over their premature baby formulas' risks.

Abbott Laboratories (NYSE:ABT), together with its subsidiaries, discovers, develops, manufactures and sells health care products worldwide. It is set to report its Q4 2024 earnings on Jan.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In the last three months, 15 analysts have published ratings on Abbott Laboratories (NYSE:ABT), offering a diverse range of perspectives from bullish to bearish. The table below summarizes their ...